TORONTO, ONTARIO--(Marketwired - May 20, 2015) - BlueOcean NutraSciences (TSX VENTURE:BOC) ("BlueOcean" or the "Company"), a nutraceutical company focused on developing premium quality specialty oils used in Health and Wellness markets, is pleased to announce that Mr. Gavin Bogle, CEO and Director of BlueOcean will present at the Canada India HealthCare Summit. The event is organized by the Canada India Foundation and is being held in Toronto from May 19th to 20th, 2015.
"We are delighted and honored to have been invited to speak at the Canada India Healthcare Summit and meet with business and key opinion leaders in their respective areas. BlueOcean's existing relationships with our Indian suppliers is an integral aspect of our business and we recognize the importance of our product portfolio for the South Asian Market," said Mr. Bogle.
The summit will discuss South Asian health issues, rehabilitation, long-term care, digital health and smart hospitals, distance care, rural care, pharmaceuticals and generic drugs, research collaboration, wellness, alternative healthcare policy and general healthcare policy as well as explore business and investment opportunities in healthcare in Canada and India. More than 60 speakers and leaders in healthcare from India and Canada will be speaking at the event. Speakers and participants will include senior executives from Indian companies such as Apollo Hospitals, P.D. Hinduja Hospital, Cadila Pharmaceuticals, Aurobindo Pharmaceuticals, Sankara Nethralaya, Aravind Eye Care, Dr. Agarwal Hospitals, and Asian Bariatrics. They will be joined by Canadian companies such by Apotex, Meditech, Teknoscan, hospital systems such as Toronto Rehab, Sick Kids, William Osler Health Centre, Markham Stouffville Hospital, Trillium Health Centre and by Canadian universities (University of Toronto, University of British Columbia, McMaster University, McGill University and York University).
Mr. Bogle will be presenting in the Wellness and Alternative Healthcare category from 1:00pm to 2:15pm EST on May 20th. Mr.Bogle's presentation slides can be viewed at: http://blueoceannutra.ca/wp-content/uploads/2015/05/BOC-Gavin-Bogle-Canada-India-slides-final-final-final.pdf
About BlueOcean NutraSciences Inc.
BlueOcean NutraSciences Inc. is a Canadian listed public company (TSXV:BOC) that is focused on developing sustainable, specialty nutraceutical oil products targeted at the rapidly growing Natural Astaxanthin, Omega-3 and Algal oil health and wellness markets.
BlueOcean is developing two specialty oil product lines: AstaShrimpTM and AlgaOmegaTM, and BlueOcean and its JV partner, CMAX technologies, have developed a process to convert shrimp, krill, algae and other fish oils into Extended Release Tablets.
BlueOcean owns 50% of the participating and voting rights in 70717 Newfoundland and Labrador Ltd, a joint venture with a major Atlantic Canada shrimp processor that provides the shrimp feedstock for the extraction of Northern AstaShrimpTM, and BlueOcean wholly owns the rights to produce and sell its Pacific and Southern AstaShrimpTM oils. BlueOcean wholly owns its AlgaOmegaTM product line. BlueOcean owns 50% of the participating and voting rights in 2453969 Ontario Inc., a joint venture with CMAX Technologies that has developed extended release omega-3/astaxanthin tablets.
The natural oils to be used in AstaShrimpTM contain very high levels of naturally occurring astaxanthin, phospholipids, and omega-3 EPA and DHA. AstaShrimpTM will be targeted at the high value and rapidly growing natural astaxanthin market. AlgaOmegaTM oil is vegetarian, non-GMO omega-3 algal oil containing high levels of EPA with Polar Lipids and is targeted at the rapidly growing omega-3 algal oil ingredient market. The extended release tablets target the rapidly growing omega-3 consumer market and astaxanthin consumer dietary supplements markets.
Forward Looking Statements: BlueOcean
This news release may contain forward-looking statements that are based on BlueOcean's expectations, estimates and projections regarding its business and the economic environment in which it operates. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. Statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.